Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PEDIATRICS TO PARENTS MEDICAL, PC

NPI: 1912189085 · TAZEWELL, TN 37879 · Multi-Specialty Clinic/Center · NPI assigned 11/30/2007

$885K
Total Medicaid Paid
56,266
Total Claims
46,863
Beneficiaries
68
Codes Billed
2018-01
First Month
2024-10
Last Month

Provider Details

Authorized OfficialFEJERAN, RONALD (PRESIDENT AND PHYSICIAN)
NPI Enumeration Date11/30/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,177 $134K
2019 9,818 $172K
2020 7,976 $132K
2021 9,245 $125K
2022 7,581 $111K
2023 8,435 $122K
2024 6,034 $88K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12,268 10,064 $438K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8,268 6,887 $242K
80305 12,716 10,721 $48K
90460 Immunization administration through 18 years of age via any route, first or only component 1,217 1,014 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,753 1,424 $17K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 223 182 $16K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 158 126 $11K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 82 66 $7K
96127 1,932 1,616 $6K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 183 168 $6K
99406 936 796 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 447 261 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 438 375 $4K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 69 51 $4K
90688 481 432 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 248 225 $3K
36415 Collection of venous blood by venipuncture 3,245 2,816 $3K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 276 172 $2K
81002 1,107 927 $2K
83036 Hemoglobin; glycosylated (A1C) 1,430 1,175 $2K
99173 745 633 $2K
93000 245 219 $2K
90686 357 325 $2K
92552 61 61 $1K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 18 18 $1K
94060 23 18 $924.43
G0442 Annual alcohol misuse screening, 5 to 15 minutes 228 200 $858.33
J1071 Injection, testosterone cypionate, 1 mg 254 178 $752.43
82044 406 318 $744.25
90658 72 69 $444.46
36416 541 480 $429.92
93922 13 13 $409.52
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 12 12 $343.75
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 573 481 $302.12
83037 44 39 $167.98
96161 95 78 $155.95
J1100 Injection, dexamethasone sodium phosphate, 1 mg 268 228 $110.67
82270 52 50 $98.70
85018 56 44 $78.98
G0444 Annual depression screening, 5 to 15 minutes 325 236 $77.45
G0008 Administration of influenza virus vaccine 264 246 $52.28
90461 214 163 $34.19
3044F 482 420 $20.00
J0696 Injection, ceftriaxone sodium, per 250 mg 14 14 $13.09
90749 79 60 $9.30
3078F 52 46 $0.00
1160F 32 25 $0.00
90670 21 17 $0.00
1159F 92 80 $0.00
90648 20 16 $0.00
4004F 113 95 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 13 12 $0.00
3008F 1,059 844 $0.00
3352F 208 185 $0.00
3074F 18 15 $0.00
3351F 351 276 $0.00
G9226 Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) 118 86 $0.00
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) 433 380 $0.00
3353F 59 52 $0.00
G9903 Patient screened for tobacco use and identified as a tobacco non-user 371 301 $0.00
3061F 46 38 $0.00
1170F 91 80 $0.00
1125F 88 79 $0.00
1036F 98 77 $0.00
90723 17 13 $0.00
90656 13 13 $0.00
3354F 19 19 $0.00
3075F 16 13 $0.00